VIRACTA THERAPEUTICS INC (VIRX) Stock Analyst Earnings Estimates
NASDAQ:VIRX - Nasdaq - US92765F1084 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 240K -64.18% | 2.07M 762.50% | 120K -94.20% | -100.00% | 15.514M | 63.113M 306.81% | 147.3M 133.39% | 196.36M 33.31% | 238.25M 21.33% | ||||||
| EBITDA YoY % growth | -25.7M 25.31% | N/A 5.08% | N/A | N/A | N/A -96.64% | N/A 0.36% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -25.71M 25.31% | -23.29M 9.41% | -22.3M 4.25% | -123.372M -15.70% | -54.921M -96.09% | -51.4M -0.20% | -44.574M 12.07% | -38.25M 14.19% | -47.736M -24.80% | -44.554M 6.67% | -15.536M 65.13% | 57.701M 471.41% | 97.158M 68.38% | 131.55M 35.40% | |
| Operating Margin | -10,712.50% | -1,125.12% | -18,583.33% | N/A | N/A | N/A | N/A | N/A | N/A | -287.18% | -24.62% | 39.17% | 49.48% | 55.22% | |
| EPS YoY % growth | -26.25 50.66% | -10.50 60.00% | -5.60 46.67% | -3.79 89.11% | -1.43 -113.11% | -1.30 -1.54% | -0.82 38.18% | -0.37 55.00% | -0.41 -11.11% | -0.33 20.00% | -0.08 75.00% | 0.42 612.50% | 0.66 58.54% | 0.86 29.23% |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -0.13 62.11% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -10.2M 24.78% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.27 18.18% | -0.25 | -0.02 | -8.04% |
| Q2 2024 Q2Q % growth | -0.25 21.88% | -0.38 | 0.13 | 33.76% |
| Q1 2024 Q2Q % growth | -0.23 28.13% | -0.36 | 0.13 | 36.03% |
| Q4 2023 Q2Q % growth | -0.35 -29.63% | -0.32 | -0.03 | -10.69% |
| Q3 2023 Q2Q % growth | -0.33 29.79% | -0.31 | -0.02 | -6.08% |
| Q2 2023 Q2Q % growth | -0.32 -14.29% | -0.30 | -0.02 | -8.18% |
| Q1 2023 Q2Q % growth | -0.32 -14.29% | -0.32 | 0.00 | -0.39% |
| Q4 2022 Q2Q % growth | -0.27 12.90% | -0.39 | 0.12 | 31.25% |
| Q3 2022 Q2Q % growth | -0.47 -17.50% | -0.31 | -0.16 | -51.08% |
| Q2 2022 Q2Q % growth | -0.28 -12.00% | -0.30 | 0.02 | 7.73% |
| Q1 2022 Q2Q % growth | -0.28 -180.00% | -0.32 | 0.04 | 12.85% |
| Q4 2021 Q2Q % growth | -0.31 57.82% | -0.44 | 0.13 | 30.13% |
| Q3 2021 Q2Q % growth | -0.40 60.59% | -0.32 | -0.08 | -26.50% |
| Q2 2021 Q2Q % growth | -0.25 88.10% | -0.24 | -0.01 | -3.56% |
| Q1 2021 Q2Q % growth | 0.35 120.00% | -0.21 | 0.56 | 263.40% |
| Q4 2020 Q2Q % growth | -0.74 58.00% | -0.98 | 0.25 | 25.13% |
| Q3 2020 Q2Q % growth | -1.02 51.67% | -1.20 | 0.19 | 15.55% |
| Q2 2020 Q2Q % growth | -2.10 33.33% | -1.98 | -0.12 | -5.99% |
| Q1 2020 Q2Q % growth | -1.75 50.00% | -2.49 | 0.74 | 29.72% |
| Q4 2019 Q2Q % growth | -1.75 | -2.63 | 0.88 | 33.53% |
| Q3 2019 Q2Q % growth | -2.10 | -3.03 | 0.93 | 30.80% |
| Q2 2019 Q2Q % growth | -3.15 | -3.54 | 0.39 | 11.10% |
| Q1 2019 Q2Q % growth | -3.50 | -6.19 | 2.69 | 43.41% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2021 Q2Q % growth | -100.00% | 4.59M | -4.59M | -100.00% |
| Q4 2020 Q2Q % growth | -100.00% | % | ||
| Q2 2020 Q2Q % growth | 191.25K | -191.25K | -100.00% | |
| Q1 2020 Q2Q % growth | 120K | 191.25K | -71.25K | -37.25% |
| Q4 2019 Q2Q % growth | 2.07M | 318.75K | 1.751M | 549.41% |
| Q3 2019 Q2Q % growth | 204K | -204K | -100.00% | |
| Q2 2019 Q2Q % growth | 153K | -153K | -100.00% | |
| Q1 2019 Q2Q % growth | 459K | -459K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 33.33% | 56.18% | 0% | 8.05% |
| Revenue | N/A | N/A | N/A | N/A |